Valuation Shift: From Fair to Attractive
The most significant catalyst for the rating upgrade is the change in Primo Chemicals’ valuation grade, which has moved from fair to attractive. The company currently trades at a price-to-earnings (PE) ratio of 36.94, which, while elevated, is comparatively lower than several peers in the commodity chemicals industry. For instance, Stallion India and Sanstar Chemicals trade at PE ratios of 49.86 and 60.78 respectively, indicating that Primo’s shares are relatively more reasonably priced.
Further valuation multiples reinforce this view. The enterprise value to EBITDA (EV/EBITDA) ratio stands at 10.28, significantly below Stallion India’s 30.85 and Sanstar’s 51.86, suggesting a discount on an operational earnings basis. The PEG ratio, a key indicator of valuation relative to earnings growth, is exceptionally low at 0.11, signalling that the stock is undervalued relative to its earnings growth potential. This contrasts sharply with peers such as Titan Biotech, whose PEG ratio is 1.55, and Indo Borax & Chemicals, which has an anomalously high PEG of 27.11.
Other valuation metrics such as price-to-book value (1.41), EV to capital employed (1.32), and EV to sales (1.25) further support the attractive valuation thesis. These figures indicate that Primo Chemicals is trading at a discount relative to its asset base and sales, making it an appealing proposition for value-oriented investors.
Financial Trend: Robust Quarterly Performance
Primo Chemicals’ financial performance in the latest quarter (Q4 FY25-26) has been a key driver behind the upgrade. The company reported a profit before tax less other income (PBT LESS OI) of ₹2.16 crores, representing a staggering growth of 1083.6% compared to the previous four-quarter average. This sharp increase in profitability signals a potential turnaround in operational efficiency and earnings quality.
Additionally, the company’s debt-equity ratio has improved to a low 0.32 times as of the half-year mark, indicating a conservative capital structure and reduced financial risk. The operating profit to interest ratio has also reached a peak of 4.90 times, underscoring the company’s enhanced ability to service debt from operational earnings. These metrics collectively suggest a strengthening financial foundation that supports the positive rating revision.
Despite these improvements, it is important to note that Primo Chemicals’ return on capital employed (ROCE) remains modest at 2.95%, and return on equity (ROE) is similarly low at 3.83%. While these returns are below industry averages, the company’s valuation discounts and improving profitability trends provide a compelling case for investors willing to look beyond short-term metrics.
Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!
- - Reliable Performer certified
- - Consistent execution proven
- - Large Cap safety pick
Quality Assessment: Mixed Signals Amid Growth Challenges
While Primo Chemicals’ recent quarterly results are encouraging, the company’s long-term quality indicators present a more nuanced picture. Operating profit has declined at an annualised rate of -30.88% over the past five years, signalling challenges in sustaining growth momentum. This trend raises concerns about the company’s ability to generate consistent earnings growth over the medium to long term.
Moreover, Primo Chemicals has underperformed the benchmark indices consistently. Over the last three years, the stock has lagged the BSE500 index in each annual period, with a one-year return of -12.54% compared to the benchmark’s -5.43%. Over a three-year horizon, the stock’s return has been a steep -62.94%, while the Sensex gained 21.73%. This persistent underperformance highlights the risks investors face despite the recent upgrade.
Nonetheless, the company’s ten-year return of 727.29% significantly outpaces the Sensex’s 189.78%, reflecting strong historical wealth creation for long-term investors. This dichotomy between recent underperformance and long-term gains suggests that Primo Chemicals may be in a transitional phase, with potential for recovery if recent positive trends continue.
Technicals: Price Movements and Market Sentiment
From a technical perspective, Primo Chemicals’ share price has shown volatility in recent sessions. The stock closed at ₹23.71 on 18 June 2026, down 1.66% from the previous close of ₹24.11. The intraday range was between ₹23.60 and ₹24.75, with a 52-week high of ₹31.44 and a low of ₹16.21. This wide trading range indicates significant price fluctuations, reflecting mixed investor sentiment.
Despite the recent dip, the stock remains closer to its lower 52-week range, suggesting potential undervaluation from a technical standpoint. However, the lack of sustained upward momentum and the stock’s underperformance relative to the Sensex and sector peers caution investors to monitor price action closely before committing fresh capital.
Thinking about Primo Chemicals Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this micro-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Peer Comparison and Market Positioning
Within the commodity chemicals sector, Primo Chemicals is classified as a micro-cap stock, which inherently carries higher volatility and risk compared to larger peers. Its valuation metrics, particularly the attractive EV to capital employed ratio of 1.32, position it favourably against competitors such as Stallion India and Sanstar Chemicals, which trade at much higher multiples.
The company’s PEG ratio of 0.11 is among the lowest in its peer group, indicating that the market may be undervaluing its earnings growth potential. This is a critical factor for investors seeking growth at a reasonable price. However, the relatively low ROCE and ROE figures suggest that operational efficiency and capital utilisation remain areas for improvement.
Majority shareholding remains with non-institutional investors, which may impact liquidity and trading volumes. This ownership structure can sometimes lead to increased price volatility, a factor investors should consider when evaluating the stock.
Risks and Considerations
Despite the upgrade, investors should be mindful of the risks associated with Primo Chemicals. The company’s long-term operating profit decline and consistent underperformance against benchmarks highlight structural challenges. The micro-cap status also implies limited market liquidity and potentially higher susceptibility to market swings.
Furthermore, the company’s modest returns on capital and equity indicate that while valuation is attractive, operational improvements are necessary to sustain growth and justify the upgraded rating. Investors should weigh these factors carefully against the recent positive financial trends and valuation discounts.
Conclusion: A Cautiously Optimistic Outlook
Primo Chemicals Ltd’s upgrade to a Buy rating reflects a combination of improved valuation metrics, strong quarterly financial performance, and a low PEG ratio signalling undervaluation relative to earnings growth. While the company faces challenges in long-term growth and has underperformed its benchmarks, the recent operational improvements and attractive pricing provide a compelling entry point for investors with a higher risk tolerance.
Market participants should monitor upcoming quarterly results and sector developments closely to assess whether Primo Chemicals can sustain its turnaround momentum. For now, the upgrade by MarketsMOJO to a Mojo Grade of Buy with a score of 71.0 signals renewed investor confidence in the company’s prospects within the commodity chemicals sector.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
